Does myofascial and trigger point treatment reduce pain and analgesic intake in patients undergoing OnabotulinumtoxinA injection due to chronic intractable migraine? A pilot, single-blind randomized controlled trial.

CONCLUSIONS: Manipulative techniques aimed at reducing peripheral nociceptive triggers might add value in the management of chronic migraine symptoms and lower acute medication use.
CLINICAL REHABILITATION IMPACT: An interdisciplinary approach comprising pharmacological and non- pharmacological strategies can reduce analgesic consumption and myofascial dysfunction symptoms in chronic migraine patients.
PMID: 28750504 [PubMed - as supplied by publisher]

Source: Physica Medica - July 27, 2017 Category: Physics Authors: Gandolfi M, Geroin C, Valè N, Marchioretto F, Turrina A, Dimitrova E, Tamburin S, Serina A, Castellazzi P, Meschieri A, Ricard F, Saltuari L, Picelli A, Smania N Tags: Eur J Phys Rehabil Med Source Type: research